reviewEndocrine ReviewsOct 1, 2004BRONZE OA

11β-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response

Queen Elizabeth Hospital Birmingham · University of Birmingham

PubMed
Indexed incrossrefpubmed

Abstract

11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) interconverts inactive cortisone and active cortisol. Although bidirectional, in vivo it is believed to function as a reductase generating active glucocorticoid at a prereceptor level, enhancing glucocorticoid receptor activation. In this review, we discuss both the genetic and enzymatic characterization of 11beta-HSD1, as well as describing its role in physiology and pathology in a tissue-specific manner. The molecular basis of cortisone reductase deficiency, the putative "11beta-HSD1 knockout state" in humans, has been defined and is caused by intronic mutations in HSD11B1 that decrease gene transcription together with mutations in hexose-6-phosphate…

Citation impact

969
total citations
FWCI
26.67
Percentile
100%
References
428
Citations per year

Authors

8

Topics & keywords

Keywords
  • Dehydrogenase
  • Nicotinamide adenine dinucleotide phosphate
  • Nicotinamide adenine dinucleotide
  • 11β-hydroxysteroid dehydrogenase type 1
  • Cortisone
  • Glucocorticoid
  • Flavin adenine dinucleotide
  • Cofactor
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.